D.E. Shaw & Co
VKTX icon

D.E. Shaw & Co’s Viking Therapeutics VKTX Stock Holding History

D.E. Shaw & Co’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-138,400
Closed -$4.87M – 5097
2025
Q4 		$4.87M Hold
138,400
– – ﹤0.01% 2320
2025
Q3 		$3.64M Buy
138,400
+114,900
+489% +$3.43M ﹤0.01% 2495
2025
Q2 		$623K Hold
23,500
– – ﹤0.01% 3540
2025
Q1 		$568K Sell
23,500
-30,000
-56% -$948K ﹤0.01% 3434
2024
Q4 		$2.15M Hold
53,500
– – ﹤0.01% 2666
2024
Q3 		$3.39M Buy
53,500
+3,500
+7% +$205K ﹤0.01% 2270
2024
Q2 		$2.65M Hold
50,000
– – ﹤0.01% 2386
2024
Q1 		$4.1M Buy
+50,000
New +$2.22M ﹤0.01% 2038

Other funds holding VKTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return